Percutaneous Imaging-Guided versus Open Musculoskeletal Biopsy: Concepts and Controversies

2020 ◽  
Vol 24 (06) ◽  
pp. 667-675
Author(s):  
Violeta Vasilevska Nikodinovska ◽  
Slavcho Ivanoski ◽  
Milan Samardziski ◽  
Vesna Janevska
Keyword(s):  
Soft Tissue ◽  
Complication Rate ◽  
Core Needle Biopsy ◽  
Multidisciplinary Team ◽  
Gold Standard ◽  
Needle Biopsy ◽  
Soft Tissue Tumors ◽  
Open Biopsy ◽  
Core Needle ◽  
Similar Accuracy

AbstractBone and soft tissue tumors are a largely heterogeneous group of tumors. Biopsy of musculoskeletal (MSK) tumors is sometimes a challenging procedure. Although the open biopsy is still considered the gold standard for the biopsy of MSK lesions, core needle biopsy can replace it in most cases, with similar accuracy and a low complication rate. The biopsy should be performed in a tertiary sarcoma center where the multidisciplinary team consists of at minimum a tumor surgeon, an MSK pathologist, and an MSK radiologist who can assess all steps of the procedure. Several factors can influence the success of the biopsy including the lesion characteristics, the equipment, and the method used for the procedure. This review highlights some of the important aspects regarding the biopsy of the MSK tumors, with special attention to imaging a guided core needle biopsy and highlighting some of the recent advancements and controversies in the field.

Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses

2003 ◽  
Vol 39 (14) ◽  
pp. 2021-2025 ◽  
Author(s):  
I. Ray-Coquard ◽  
D. Ranchère-Vince ◽  
P. Thiesse ◽  
H. Ghesquières ◽  
P. Biron ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Open Biopsy ◽  
Core Needle ◽  
Soft Tissue Masses

scholarly journals Core needle biopsy of soft tissue tumors, CEUS vs US guided: a pilot study

2015 ◽  
Vol 18 (4) ◽  
pp. 335-342 ◽  
Author(s):  
Alessandro Coran ◽  
Antonio Di Maggio ◽  
Marco Rastrelli ◽  
Enrico Alberioli ◽  
Shady Attar ◽  
...  
Keyword(s):  
Pilot Study ◽  
Soft Tissue ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Soft Tissue Tumors ◽  
Core Needle

Sonographically Guided Core Needle Biopsy of Bone and Soft Tissue Tumors

2002 ◽  
Vol 21 (3) ◽  
pp. 275-281 ◽  
Author(s):  
Martin Torriani ◽  
Mauricio Etchebehere ◽  
Eliane Maria Ingrid Amstalden
Keyword(s):  
Soft Tissue ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Soft Tissue Tumors ◽  
Core Needle

High diagnostic accuracy of core needle biopsy of soft tissue tumors: An institutional experience

2016 ◽  
Vol 44 (4) ◽  
pp. 291-298 ◽  
Author(s):  
Shanna M. Colletti ◽  
Ghassan A. Tranesh ◽  
Chantel R. Whetsell ◽  
Larissa N. Chambers ◽  
Aziza Nassar
Keyword(s):  
Soft Tissue ◽  
Diagnostic Accuracy ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Soft Tissue Tumors ◽  
Core Needle ◽  
High Diagnostic Accuracy ◽  
Institutional Experience

scholarly journals Percutaneous Core Needle Biopsy Can Efficiently and Safely Diagnose Most Primary Bone Tumors

Diagnostics ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 1552
Author(s):  
Vincent Crenn ◽  
Léonard Vezole ◽  
Amine Bouhamama ◽  
Alexandra Meurgey ◽  
Marie Karanian ◽  
...  
Keyword(s):  
Complication Rate ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Bone Tumors ◽  
First Line ◽  
Surgical Biopsy ◽  
Core Needle ◽  
Reference Center ◽  
Referral Center ◽  
Percutaneous Core Needle Biopsy

A biopsy is a prerequisite for the diagnosis and evaluation of musculoskeletal tumors. It is considered that surgical biopsy provides a more reliable diagnosis because it can obtain more tumor material for pathological analysis. However, it is often associated with a significant complication rate. Imaging-guided percutaneous core needle biopsy (PCNB) is now widely used as an alternative to surgical biopsy; it appears to be minimally invasive, possibly with lower complication rates. This study evaluates the diagnostic yield of the preferred use of PCNB in a referral center, its accuracy, and its complication rate. The data relating to the biopsy and the histological analysis were extracted from the database of a bone tumor reference center where PCNB of bone tumors was discussed as a first-line option. 196 bone tumors were biopsied percutaneously between 2016 and 2020. They were located in the axial skeleton in 21.4% (42) of cases, in the lower limb in 58.7% (115), and in the upper limb in 19.9% (39) cases. We obtained a diagnosis yield of 84.7% and a diagnosis accuracy of 91.7%. The overall complication rate of the percutaneous biopsies observed was 1.0% (n = 2), consisting of two hematomas. PCNB performed in a referral center is a safe, precise procedure, with a very low complication rate, and which avoids the need for first-line open surgical biopsy. The consultation between pathologist, radiologist, and clinician in an expert reference center makes this technique an effective choice as a first-line diagnosis tool.

Evaluation of a Soft Tissue Mass in the Extremity or Trunk

2018 ◽  
Author(s):  
Daniel C Thomas ◽  
Dale Han
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Physical Examination ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Malignant Tumors ◽  
Soft Tissue Mass ◽  
Tissue Mass ◽  
Core Needle ◽  
Needle Tract

Soft tissue sarcoma (STS) represents a diverse group of malignant tumors derived from mesenchymal elements. Evaluation of a soft tissue mass of the trunk or extremity starts with a detailed history and physical examination, which will help guide further diagnostic evaluation.  Imaging should then be obtained for an STS, with MRI being the preferred modality for the trunk or extremities. Imaging can assist with diagnosis and delineate the extent of the primary lesion, including the relationship to contiguous structures, for treatment planning and assessing resectability. Pathology diagnosis is most commonly performed via examination of a specimen obtained through image-guided percutaneous core-needle biopsy. This requires multidisciplinary planning between Surgery and Radiology to place the needle within the anticipated definitive surgical incision to allow for en bloc resection of the needle tract. Once the diagnosis of an STS is made, appropriate staging studies should be performed based on the history and physical examination and tumor histology, grade, and size. Clinical and pathology data are used to stage STS patients using the American Joint Committee on Cancer staging system, which incorporates the STS site, size and grade of the primary tumor, and absence or presence of nodal and distant metastatic disease. This review contains 6 figures, 6 tables and 50 references Key words: core-needle biopsy, extremity, histology, imaging, risk factors, soft tissue mass, soft tissue sarcoma, staging evaluation, trunk, tumor grade

Image-guided percutaneous core needle biopsy of soft-tissue masses in the pediatric population

2016 ◽  
Vol 46 (8) ◽  
pp. 1173-1178 ◽  
Author(s):  
Terrence Metz ◽  
Amer Heider ◽  
Ranjith Vellody ◽  
Marcus D. Jarboe ◽  
Joseph J. Gemmete ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Pediatric Population ◽  
Core Needle ◽  
Image Guided ◽  
Percutaneous Core Needle Biopsy ◽  
Soft Tissue Masses
Sign in / Sign up

Export Citation Format

Share Document